首页> 中文期刊> 《中国卫生标准管理》 >血清胆红素、糖化血红蛋白及血脂联合检验在2型糖尿病合并冠心病的临床作用分析

血清胆红素、糖化血红蛋白及血脂联合检验在2型糖尿病合并冠心病的临床作用分析

         

摘要

Objective To analyze serum bilirubin(TBIL),glycosylated hemoglobin(HbA1c)and blood fat joint inspection in type 2 diabetes melitus(T2DM) with coronary heart disease(CHD)in clinical effect.Methods From August 2013 to December 2015,140 T2DM patients of our hospital as research target,according to whether the combination of CHD were divided into group A(n=78, unincorporated CHD)and group B (n=62, with CHD). TBIL,HbA1c,blood lipids and other indicators for testing in 2 groups of patients, the test results were compared.ResultsCompared with A group, B group of HDL-C,TBIL decreased in patients,with LDL-C、HbA1c、TC、TG increased,the difference between the 2 groups had statistical significance(P<0.05). Conclusion TBIL,HbA1c,blood lipid joint detection were helpful for accurate diagnosis whether type 2 diabetes melitus with coronary heart disease,provide guidance for clinical diagnosis and treatment.%目的:分析血清胆红素(TBIL)、糖化血红蛋白(HbA1c)及血脂联合检验在2型糖尿病(T2DM)合并冠心病(CHD)的临床作用。方法选取2013年8月~2015年12月我院收治的140例T2DM患者作为观察目标,按照其是否合并CHD分为A组(n=78,未合并CHD)和B组(n=62,合并CHD),对2组患者TBIL、HbA1c、血脂等指标进行检测,比较检测结果的差异性。结果与A组患者相比,B组患者TBIL、HDL-C降低,LDL-C、HbA1c、TC、TG升高,2组间比较差异具有统计学意义(P<0.05)。结论 TBIL、HbA1c、血脂联合检测有利于准确诊断2型糖尿病是否合并冠心病,为临床选择针对性诊疗方法提供指导信息。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号